Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03165994
Title APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

esophagus adenocarcinoma

esophageal carcinoma

esophagus squamous cell carcinoma

gastroesophageal junction adenocarcinoma

Therapies

APX005M + Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Tucson Arizona 85719 United States Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
MedStar Georgetown University Hospital (MGUH) Washington District of Columbia 20007-2113 United States Details
New York University New York New York 10016 United States Details
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7305 United States Details
Wake Forest School of Medicine Winston-Salem North Carolina 27157 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Renovatio Clinical The Woodlands Texas 77380 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field